Dr. Philip A. Chan joined GoLocal to discuss the new wave of weight loss drugs and their implications for fighting obesity as well as their implications for other applications like kidney disease and ...
People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...
Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...
Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
Influencer and podcast maven Claudia Oshry used Ozempic to kickstart a newfound wellness journey.
As drugs like Ozempic and Mounjaro continue to skyrocket in usage, doctors are encountering more cases linking them to ...
Find out if it's safe to drink alcohol during your Ozempic treatment, whether alcohol raises the risk of any sides effects, ...
An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, ...
Lupin has received tentative approval from the Food and Drug Administration for darunavir, cobicistat, emtricitabine, and ...
A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.
Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...
A new study suggests that semaglutide, a drug commonly used for diabetes and obesity, may also help reduce alcohol ...